Project Grant HT94252410734
Award Date
7/15/24
Completion Date
7/14/27
Dollars Obligated
$686K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Athens, GA 30602, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $568,687 to Emory University to develop novel radiogenomic tools for predicting outcomes for small cell lung cancer patients treated with chemoimmunotherapy. The project, with a performance period from February 1, 2024 to January 31, 2027, aims to advance scientific knowledge and improve clinical outcomes in this patient population through...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $187,800.00 to Emory University to conduct research on "ENHANCING RADIOSENSITIVITY IN CHD5-DEPLETED LUNG ADENOCARCINOMA THROUGH INHIBITION OF NONHOMOLOGOUS END JOINING (NHEJ)." The research aims to investigate innovative approaches to enhance the effectiveness of radiation therapy for lung cancer, particularly in cases where the CHD5 gene is...
The Department of the Army Medical Command awarded a $464,165 Project Grant to the University of Georgia Research Foundation to develop a "Therapeutic Potency Testing Using a Perfusable Multi-Niche Glioblastoma-on-Chip Platform". This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military personnel and the public. As part of this project, the University of Georgia...
The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
The Defense Health Agency awarded a $845,250 Project Grant to Duke University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from July 1, 2025 to June 30, 2028, supports research to engineer TCR-T cells to target human endogenous retroviruses for non-small cell lung cancer immunotherapy. Duke University, a prominent private research university, will lead this advanced biomedical research initiative to develop...